Figure 1.

Forest plot of incidence rate ratios for studies included in the pooled analysis. Studies evaluated child mortality rates in communities receiving mass drug administration with azithromycin compared with control (placebo distribution in Macrolide Oraux pour Réduire les Décès avec un Oeil sur la Résistance [MORDOR], annual azithromycin in Partnership for the Rapid Elimination of Trachoma [PRET], and delayed treatment in Trachoma Amelioration in Northern Amhara [TANA]). Data were included for children aged 1–59 months in MORDOR, 6–59 months in PRET, and 12–59 months in TANA.